These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20067754)

  • 41. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii.
    Saavedra R; Leyva R; Tenorio EP; Haces ML; Rodríguez-Sosa M; Terrazas LI; Hérion P
    Parasite Immunol; 2004 Feb; 26(2):67-73. PubMed ID: 15225293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait.
    Hammami S; Schumacher C; Cliquet F; Tlatli A; Aubert A; Aubert M
    Vet Res; 1999; 30(6):607-13. PubMed ID: 10596408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.
    DiStefano D; Antonello JM; Bett AJ; Medi MB; Casimiro DR; ter Meulen J
    Vaccine; 2013 Oct; 31(42):4888-93. PubMed ID: 23941913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.
    Liu Y; Zhang S; Zhang F; Hu R
    Arch Virol; 2012 Dec; 157(12):2397-403. PubMed ID: 22886183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y; Zhang S; Ma G; Zhang F; Hu R
    Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effectiveness and safety of an immunization against parvovirus and rabies in anesthetized puppies].
    Mayr B; Hönig A; Gutbrod F; Wiedemann C
    Tierarztl Prax; 1990 Apr; 18(2):165-9. PubMed ID: 2161572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacillus atrophaeus inactivated spores as a potential adjuvant for veterinary rabies vaccine.
    Oliveira-Nascimento L; Caricati AT; Abdulack-Lopes F; Neves LC; Caricati CP; Penna TC; Stephano MA
    Vaccine; 2012 May; 30(23):3351-4. PubMed ID: 22449426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine.
    Taillardet M; Haffar G; Mondière P; Asensio MJ; Pléau-Pison T; Burdin N; Defrance T; Genestier L
    J Infect Dis; 2010 Aug; 202(3):470-9. PubMed ID: 20575660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants.
    Shi W; Kou Y; Xiao J; Zhang L; Gao F; Kong W; Su W; Jiang C; Zhang Y
    Vaccine; 2018 Aug; 36(33):5020-5029. PubMed ID: 30037417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.
    Xiao XX; Zhang Y; Liu JX; Wei QL; Yin XP
    Arch Virol; 2016 Mar; 161(3):685-91. PubMed ID: 26650039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PyNTTTTGT prototype oligonucleotide IMT504, a novel effective adjuvant of the FMDV DNA vaccine.
    Zhao G; Jin H; Li J; Su B; Du X; Kang Y; Wang X; Wang B
    Viral Immunol; 2009 Apr; 22(2):131-8. PubMed ID: 19327000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staphylococcal enterotoxin C2 as an adjuvant for rabies vaccine induces specific immune responses in mice.
    Yao S; Li Y; Zhang Q; Zhang H; Zhou L; Liao H; Zhang C; Xu M
    Pathog Dis; 2018 Jul; 76(5):. PubMed ID: 29860490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concomitant administration of GonaCon™ and rabies vaccine in female dogs (Canis familiaris) in Mexico.
    Vargas-Pino F; Gutiérrez-Cedillo V; Canales-Vargas EJ; Gress-Ortega LR; Miller LA; Rupprecht CE; Bender SC; García-Reyna P; Ocampo-López J; Slate D
    Vaccine; 2013 Sep; 31(40):4442-7. PubMed ID: 23871822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy.
    Chapat L; Hilaire F; Bouvet J; Pialot D; Philippe-Reversat C; Guiot AL; Remolue L; Lechenet J; Andreoni C; Poulet H; Day MJ; De Luca K; Cariou C; Cupillard L
    Vet Immunol Immunopathol; 2017 Jul; 189():58-65. PubMed ID: 28669388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity.
    Yang L; Wu X; Wan M; Yu Y; Yu Y; Wang L
    Int Immunopharmacol; 2013 Jan; 15(1):89-96. PubMed ID: 23142503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine.
    Zhang W; Zheng X; Cheng N; Gai W; Xue X; Wang Y; Gao Y; Shan J; Yang S; Xia X
    Int J Biol Macromol; 2016 Jun; 87():7-15. PubMed ID: 26875535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of a novel nanoemulsion adjuvant for rabies vaccine which stabilizes a Krebs cycle intermediate (SDH) in an animal model.
    Ze L; Zonglin L; Ya'Nan W; Shaohui S; Huijuan Y; Wei C; Li W; Liao G
    Hum Vaccin Immunother; 2019; 15(2):388-396. PubMed ID: 30299210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.